Ursodeoxycholic acid therapy in primary
✍
David E. J. Jones; Oliver F. W. James; Margaret F. Bassendine
📂
Article
📅
1995
🏛
John Wiley and Sons
🌐
English
⚖ 703 KB
BackgroundlAims: A double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) was conducted in 180 patients with primary biliary cirrhosis (PBC) to define the efficacy and safety of UDCA Efficacy was assessed by time to treatment failure defined as death; liver transplantation; histologic